Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3Pain, Postoperative 3Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Pancreatic Neoplasms 2Pain 2Colonic Neoplasms 2Choledocholithiasis 2Choledochal Cyst 2Anxiety Disorders 2Urinary Bladder Neoplasms 1Terminal Cancer 1Stomach Neoplasms 1Solid Tumor 1Skin Neoplasms 1Sedation 1Rectal Neoplasms 1Postoperative Cognitive Complications 1Polyps 1Personal Satisfaction 1Patient Satisfaction 1Parasomnias 1Pancreatitis 1Pain, Intractable 1Opioid-Related Disorders 1Nausea 1Mouth Neoplasms 1Healthy 1Glioma 1

Interventions

Midazolam 2Transplantation 1Propofol 1Meperidine 1Laparoscopy 1Ketamine 1Etomidate 1Conversion to Open Surgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Choledochal Cyst × Midazolam × Clear all
NCT06111872 2025-03-25

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

National University of Malaysia

Phase 2 Completed
90 enrolled
Gastrointestinal

Cholangitis, Pancreatic Neoplasms, Choledochal Cyst, Choledocholithiasis

NCT02013986 2013-12-17

Effects of Etomidate on Postoperative Circadian Rhythm Changes of Salivary Cortisol in Children

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase 4 Unknown
30 enrolled

Choledochal Cyst, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡